2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home
|
|
- Emmeline Todd
- 6 years ago
- Views:
Transcription
1 Fluid Management 2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home
2 Objectives Define euvolemia Determine factors which contribute to fluid imbalance Discuss strategies to improve fluid overload USMP/MG1/ /16 2
3 Fluid Management Pre USMP/MG1/ /16 3
4 Fluid Management Post 2006 Maintain euvolemia with the lowest dextrose concentration 1 1 National Kidney Foundation: DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis 48:S122-S143, 2006 (suppl 1) USMP/MG1/ /16 4
5 Changes in Transport Properties with Time Adapted from Davies SJ, Bryan J, Phillips L, et al. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996;11: USMP/MG1/ /16 5
6 Glucose Exposure and Transport Characteristics Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001;12: USMP/MG1/ /16 6
7 Euvolemia Euvolemia is the normalization of extracellular volume. In dialysis this may be referred to as ideal body weight target weight, estimated dry weight or true dry weight 2 3 Guest S. Volume management in PD therapy.. In: Handbook of Peritoneal Dialysis. 2nd ed. San Bernardino, California. 2014: Mujais S, Nolph K, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. PDI 2000;Vol 20, Supp 4: S6 USMP/MG1/ /16 7
8 Strategies Fluid Assessments Dietary Management Diuretics Maintenance of Residual Renal Function Prescription Adaptation to Peritoneal Equilibration Test (PET) Blood Sugar Control Hypertonic or alternative osmotic solution 5 Mujais S, Nolph K, etal. Evaluation and management of ultrafiltration problems in peritoneal dialysis. PDI 2000;Vol 20, Supp 4: S7 USMP/MG1/ /16 8
9 Fluid Assessment Weight Blood Pressure Pulse Edema Breath Sounds Co Core Curriculum for Nephrology Nursing 5 th Ediition. American Neohrology Nurses Association 2008, pg 692 USMP/MG1/ /16 9
10 Fluid Assessment Strategies Clearly define euvolemic weight Consider defining weight ranges Determine normal blood pressure ranges Educate on self assessment of edema Jdaugirdas, PBlake, Ting, In: Handbook of Dialysis Fourth Edition Philadelphia USMP/MG1/ /16 10
11 Dietary Management Salt Restriction 3 Most patients on PD therapy will require a sodium restriction to maintain euvolemia 6 grams/day Fluid Allotment 3 Guest S. Volume management in PD therapy.. In: Handbook of Peritoneal Dialysis. 2nd ed. San Bernardino, California. 2014: 176 USMP/MG1/ /16 11
12 Dietary Management Strategies Dietitian Diet History Ongoing Education Fluid Allotment Quarterly UF/Urine output numbers to dietitian Reinforcing education National Kidney Foundation Clinical Practice Guidelines for nutrition in Chronic Renal Failure 2000 Appendice C. Appendix IV. USMP/MG1/ /16 12
13 Diuretics In patients with RKF, to achieve dry weight, diuretics may be preferred to increasing dialysate dextrose concentration 1 1 National Kidney Foundation: DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis 48:S122-S143, 2006 (suppl 1) USMP/MG1/ /16 13
14 Diuretics KDOQI Guideline States: A small randomized controlled trial showed that volume status can be improved with the use of highdose loop diuretics 1 1 National Kidney Foundation: DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis 48:S123,, 2006 (suppl 1) USMP/MG1/ /16 14
15 Diuretic Strategies In patients with RKF, to achieve dry weight, diuretics may be preferred to increasing dialysate dextrose concentration 1 What percentage of your patients with RKF are on a diuretic? 1 National Kidney Foundation: DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis 48:S143, 2006 (suppl 1) USMP/MG1/ /16 15
16 Maintenance of Residual Renal Function 4 Consequences of the loss of RRF Reduced survival Worsened blood pressure control Increased risk of volume expansion with edema formation Worsened cardiac hypertrophy Reduced middle molecule clearance Erythropoietin resistance Lower serum albumin levels Elevated calcium-phosphorus product Endothelial dysfunction 4 Guest S. Residual kidney function in PD. In: Handbook of Peritoneal Dialysis. Lexington, 2nd ed. San Bernardino, California. 2014: 44 USMP/MG1/ /16 16
17 Maintenance of RRF Strategies 4 Avoidance or cautious use of: Aminoglycosides Non-steroidal anti-inflammatory agents Contrast agents Antagonism of the renin-angiotension system Diuretics Hypertension control Avoidance of: Intravascular volume depletion Urinary tract obstruction 4 Guest S. Residual kidney function in PD. In: Handbook of Peritoneal Dialysis. 2nd ed. San Bernardino, California. 2014: 47 USMP/MG1/ /16 17
18 Prescription Management 3 Peritoneal membrane transport characteristics predict the response to an osmotic stimulus. An understanding of the underlying peritoneal membrane characteristics allows for optimization of the PD prescription 3 Guest S. Volume management in PD therapy. In: Handbook of Peritoneal Dialysis. 2nd ed. San Bernardino, California. 2014: 177 USMP/MG1/ /16 18
19 Ultrafiltration Profiles with Transport Type Net UF (ml) L LA HA H Time (hr) Adapted from: Mujais S, Vonesh E. Profiling of peritoneal ultrafiltration. Kidney Int 2002;62[Suppl 81]:S17 S21. USMP/MG1/ /16 19
20 Dwell Time and Consequence Transport Solute Clearance UF Prescription High Short dwell High A CAPD/CCPD Low A CAPD/CCPD Low Long dwell *Always try to maximize instilled volumes Adapted from: Daugirdas J, Blake P, Ing T. Handbook of Dialysis Fifth Edition, Wolters Kluwer 2015: USMP/MG1/ /16 20
21 Prescription Management Strategies 3 Adjust dwell times to match membrane characteristics High/High Average greatest UF in the first hours of the dwell so can tolerate shorter dwells Low/Low Average maintain the osmotic gradient longer and should have longer dwells to optimize the therapy Manage the long dwell Careful review of flow sheets Monitor for changes in membrane characteristics 3 Guest S. Volume management in PD therapy. In: Handbook of Peritoneal Dialysis. 2nd ed. San Bernardino, California. 2014: USMP/MG1/ /16 21
22 Blood Sugar Control Systemic hyperglycemia can interfere with fluid removal by reducing the gradient. Mujais S, Nolph K, etal. Evaluation and management of ultrafiltration problems in peritoneal dialysis. PDI 2000;Vol 20, Supp 4: S7 USMP/MG1/ /16 22
23 Blood Sugar Control Strategies Communication with Endocrinology team Use of lowest dextrose solution Mujais S, Nolph K, etal. Evaluation and management of ultrafiltration problems in peritoneal dialysis. PDI 2000;Vol 20, Supp 4: S16 USMP/MG1/ /16 23
24 Strategies Fluid Assessments Dietary Management Diuretics Maintenance of Residual Renal Function Prescription Adaptation to PET Blood Sugar Control Hypertonic or alternative osmotic solution 5 Mujais S, Nolph K, etal. Evaluation and management of ultrafiltration problems in peritoneal dialysis. PDI 2000;Vol 20, Supp 4: S7 USMP/MG1/ /16 24
25 Solution Strategies 3 Educate on importance of limiting hypertonic usage Root cause analysis for cause of fluid imbalance Rule out technical problem-constipation/catheter mal-placement Compliance with therapy/diet Short term use of hypertonic solution Use of alternative osmotic solution 3 Guest S. Volume management in PD therapy. In: Handbook of Peritoneal Dialysis 2nd ed. San Bernardino, California. 2014: 175. USMP/MG1/ /16 25
26 Fluid Management Overview Emphasis on managing fluid balance has changed Clearly define dry/target weight Diet Diuretics Maintaining residual renal function Prescription to maximize ultrafiltration Alternative osmotic solutions USMP/MG1/ /16 26
27 Thank You! Baxter is a registered trademark of Baxter International Inc. USMP/MG1/ /16
3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane
3/21/2017 Solute Clearance and Adequacy Targets in Peritoneal Dialysis Steven Guest MD Director, Medical Consulting Services Baxter Healthcare Corporation Deerfield, IL, USA Peritoneal Membrane Image courtesy
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More information02/21/2017. Assessment of the Peritoneal Membrane: Practice Workshop. Objectives. Review of Physiology. Marina Villano, MSN, RN, CNN
Assessment of the Peritoneal Membrane: Practice Workshop Marina Villano, MSN, RN, CNN marina.villano@fmc-na.com Objectives Briefly review normal peritoneal physiology including the three pore model. Compare
More informationVolume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients
Volume Management Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 14, 2017 Disclosures statement: Consultant: Allena, Becker Professional Education Grant
More informationChapter 2 Peritoneal Equilibration Testing and Application
Chapter 2 Peritoneal Equilibration Testing and Application Francisco J. Cano Case Presentation FW, a recently diagnosed patient with CKD Stage 5, is a 6-year-old boy who has been recommended to initiate
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationPERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE
PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE TABLE OF CONTENTS Introduction.... 3 SECTION 1: FUNDAMENTALS OF THE PRESCRIPTION.... 4 Getting Started: Patient Pathway to First Prescription.... 5 Volume
More informationThe peritoneal equilibration test (PET) was developed THE SHORT PET IN PEDIATRICS. Bradley A. Warady and Janelle Jennings
Peritoneal Dialysis International, Vol. 27, pp. 441 445 Printed in Canada. All rights reserved. 0896-8608/07 $3.00 +.00 Copyright 2007 International Society for Peritoneal Dialysis THE SHORT PET IN PEDIATRICS
More informationPERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE
PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE This quick reference guide will help serve as a reference tool for clinicians setting a patient s Peritoneal Dialysis (PD) prescription.
More informationEarly Estimation of High Peritoneal Permeability Can Predict Poor Prognosis for Technique Survival in Patients on Peritoneal Dialysis
Advances in Peritoneal Dialysis, Vol. 22, 2006 Hidetomo Nakamoto, 1,2 Hirokazu Imai, 2 Hideki Kawanishi, 2 Masahiko Nakamoto, 2 Jun Minakuchi, 2 Shinichi Kumon, 2 Syuichi Watanabe, 2 Yoshhiko Shiohira,
More informationPeritoneal Dialysis Prescriptions: A Primer for Nurses
Peritoneal Dialysis Prescriptions: A Primer for Nurses A Primer ABCs of PD R x Betty Kelman RN-EC MEd CNeph (C) Toronto General Hospital University Health Network Toronto, Ontario, Canada A moment to remember
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Peritoneal transport and ultrafiltration GUIDELINES
Date written: January 2004 Final submission: May 2004 Peritoneal transport and ultrafiltration GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationAna Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto
Ana Paula Bernardo CHP Hospital de Santo António ICBAS/ Universidade do Porto Clinical relevance of hyperphosphatemia Phosphate handling in dialysis patients Phosphate kinetics in PD peritoneal phosphate
More informationWhat is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test
1 2 3 What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test 4 Background information about the PET 1983 Dr. Twardowski and colleagues began measuring
More informationFree water transport: Clinical implications. Sodium sieving during short very hypertonic dialysis exchanges
Free water transport: Clinical implications Raymond T Krediet, MD,PhD University of Amsterdam Sodium sieving during short very hypertonic dialysis exchanges Nolph KD et al. Ann Int Med 1969;70:931-947
More informationad e quate adjective \ˈa-di-kwət\
PD Prescriptions and Adequacy Monitoring: The Basics Fundamentals of Dialysis in Children Seattle, Washington February 27th, 2016 Colin White Steve Alexander Brad Warady Alicia Neu Franz Schaefer Bruce
More informationSt George & Sutherland Hospitals PERITONEAL DIALYSIS UNIT RENAL DEPARTMENT Workplace Instruction (Renal_SGH_WPI_097)
PERITONEAL DIALYSIS (PD) PERITONEAL EQUILIBRATION TEST (PET) Cross references NSW Health PD2007_036 - Infection Control Policy SGH-TSH CLIN027 - Aseptic Technique - Competency and Education Requirements
More informationDEFINITIONS FOR FLUID STATUS & TARGET WEIGHT
Home Dialysis Interest Group HEALTHCARE TEAM TOOL DEFINITIONS FOR STATUS & TARGET WEIGHT BALANCED EXCESS DEFICIT Illustrations provided by: 1 BALANCE OF THE HOME HEMODIALYSIS PATIENT Dialysis Weight**
More informationImplementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018
Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018 Objectives By the end of this session the learner will
More informationContinuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study
Advances in Peritoneal Dialysis, Vol. 33, 2017 Kunal Malhotra, Ramesh Khanna Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: What, Who, Why, and How? Review and Case Study
More informationAcid-base profile in patients on PD
Kidney International, Vol. 6, Supplement 88 (23), pp. S26 S36 Acid-base profile in patients on PD SALIM MUJAIS Renal Division, Baxter Healthcare Corporation, McGaw Park, Illinois Acid-base profile in patients
More informationPERITONEAL EQUILIBRATION TEST. AR. Merrikhi. MD. Isfahan University of Medical Sciences
PERITONEAL EQUILIBRATION TEST AR. Merrikhi. MD. Isfahan University of Medical Sciences INTRODUCTION The peritoneal equilibration test (PET) is a semiquantitative assessment of peritoneal membrane transport
More informationYou can sleep while I dialyze
You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep
More informationMaher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University
Hypertension in Hemodialysis Patient Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University Mechanism of HTN in HD patients Volume-dependent HTN ECV expansion. Volume-independent HTN
More informationHow to evaluate the peritoneal membrane?
How to evaluate the peritoneal membrane? B. Bammens Brussels, May 12 2016 BELGIUM How to evaluate a hemodialyzer? How to evaluate a hemodialyzer? How to evaluate a hemodialyzer? From: Robert W. Schrier
More informationStarting Peritoneal Dialysis
PD Education Booklet 1 Starting Peritoneal Dialysis What you will learn: What your kidneys do Uremia (kidney disease) and its symptoms How Peritoneal Dialysis (PD) helps The two types of PD: Automated
More informationThere are no shortcuts to Dialysis
There are no shortcuts to Dialysis 1 Outcomes John Sweeny Wednesday, March 21 st, 2018 (3:10 pm 4:10 pm) 2 Quality in Hemodialysis Quality Health Care is the degree to which health services increases the
More informationDiabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy
Diabetes in Renal Patients Contents Understanding Diabetic Nephropathy What effect does CKD have on a patient s diabetic control? Diabetic Drugs in CKD and Dialysis Patients Hyper and Hypoglycaemia in
More informationGlucose sparing in peritoneal dialysis: Implications and metrics
http://www.kidney-international.org & 26 International Society of Nephrology Glucose sparing in peritoneal dialysis: Implications and metrics C Holmes 1 and S Mujais 1 1 Renal Division, Baxter Healthcare
More informationPD prescribing for all. QUESTION: Which approach? One size fits all or haute couture? (1) or (2)? The patient 18/03/2014.
PD prescribing for all Pr Max Dratwa Honorary consultant, Nephrology-Dialysis CHU Brugmann Université Libre de Bruxelles BSN 22 March 2014 QUESTION: Which approach? One size fits all or haute couture?
More informationIV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations
IV Fluids When administering IV fluids, the type and amount of fluid may influence patient outcomes. Make sure to understand the differences between fluid products and their effects. Crystalloids Crystalloid
More informationPhosphate Management Guideline for Patients Receiving Extended Duration Hemodialysis
IAMHD HOME HEMODIALYSIS CLINICAL PRACTICE STANDARDS AND PROCEDURES Phosphate Management Guideline for Patients Receiving Extended Duration Hemodialysis PRINTED copies of Clinical Practice Standards and
More informationStrategies to Preserve the Peritoneal Membrane. Reusz GS Ist Dept of Pediatrics Semmelweis University, Budapest
Strategies to Preserve the Peritoneal Membrane Reusz GS Ist Dept of Pediatrics Semmelweis University, Budapest Outline 1. Structure of the peritoneal membrane 2. Mechanisms of peritoneal injury 3. Signs
More informationMaintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription
Advances in Peritoneal Dialysis, Vol. 34, 2018 Susie Q. Lew Maintaining Peritoneal Dialysis Adequacy: The Process of Incremental Prescription Urea kinetics (weekly Kt/V) greater than 1.7 generally define
More informationPART ONE. Peritoneal Kinetics and Anatomy
PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.
More informationGambrosol Trio, clinical studies 91 Glitazone, malnutrition-inflammationatherosclerosis
Subject Index Acidosis, see Metabolic acidosis Activated carbon, sorbents 337 Adipokines adipose tissue and systemic inflammation 169 functions 167 169 prospects for study in renal patients 171 Adiponectin,
More informationCalcium Management for Patients Receiving Extended Duration Hemodialysis
Calcium Management for Patients Receiving Extended Duration Hemodialysis Created November 2017; Updated March 2018 Approved by the BCPRA Home Hemodialysis Committee Table of Contents 1.0 Practice Standard...1
More informationOriginal Article. Key words: Icodextrin, peritoneal dialysis, metabolic effects, ultrafiltration
Original Article 133 Clinical Experience of One-Year Icodextrin Treatment in Peritoneal Dialysis Patients Chun-Shuo Hsu *, Chien-Yu Su **, Chih-Hung Chang ***, Kao-Tai Hsu **, King-Kwan Lam **, Shang-Chih
More informationAdvances in Peritoneal Dialysis, Vol. 23, 2007
Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose
More informationIntermittent peritoneal dialysis (IPD) has occasionally
Peritoneal Dialysis International, Vol. 32, pp. 142 148 doi: 10.3747/pdi.2011.00027 0896-8608/12 $3.00 +.00 Copyright 2012 International Society for Peritoneal Dialysis INTERMITTENT PERITONEAL DIALYSIS:
More informationTHERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 2 Outline of Presentation Refinements in our understanding
More informationUltrafiltration Programs : Clinical Experiences
Ultrafiltration Programs : Clinical Experiences By : Kay Woodruff, RN, BS, CNN, Divisional Clinical Specialist Lisa Miller Hedin, RN, CNN, Senior Clinical Specialist Introduction The purpose of this article
More informationOriginal Article Effect of diuretic and ultrafiltration on edema and renal residual function in peritoneal dialysis patients
Int J Clin Exp Med 2017;10(2):3321-3328 www.ijcem.com /ISSN:1940-5901/IJCEM0045534 Original Article Effect of diuretic and ultrafiltration on edema and renal residual function in peritoneal dialysis patients
More informationPredictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran
Dialysis Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran Monir Sadat Hakemi, 1 Mehdi Golbabaei, 2 Amirahmad Nassiri, 3 Mandana
More informationMETABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
METABOLISM AND NUTRITION WITH PD OBESITY Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 Body Size in Patients New to Dialysis United States Body Mass Index, kg/m2 33 31
More informationLow Blood Pressure During Dialysis (Intradialytic Hypotension (IDH))
Low Blood Pressure During Dialysis (Intradialytic Hypotension (IDH)) By Dori Schatell, Medical Education Institute One of the main jobs of dialysis is to remove excess water from your body. Seems pretty
More informationFLUID MANAGEMENT IN DIALYSIS: STRATEGIES FOR SUCCESS
FLUID MANAGEMENT IN DIALYSIS: STRATEGIES FOR SUCCESS Quality Insights Renal Network 3 October 2, 2014 Laura D. Byham-Gray, PhD, RD Professor & Director Master of Science in Clinical Nutrition Rutgers University
More informationPhysiology of Blood Purification: Dialysis & Apheresis. Outline. Solute Removal Mechanisms in RRT
Physiology of Blood Purification: Dialysis & Apheresis Jordan M. Symons, MD University of Washington School of Medicine Seattle Children s Hospital Outline Physical principles of mass transfer Hemodialysis
More informationGeriatric Nutritional Risk Index, home hemodialysis outcomes 131
Subject Index Aksys PHD system 113 Anemia, home outcomes 111, 172, 173 Automated peritoneal dialysis dialysis comparison 17, 18 selection factors 18, 19 telemedicine system 19 21 Blood pressure -peritoneal
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES
Level of renal function at which to initiate dialysis Date written: September 2004 Final submission: February 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR
More informationSupplemental Quick Reference Guide
Supplemental Quick Reference Guide How to use this Supplemental Quick Reference Guide This guide provides a 5-step method for considering a variety of frequencies and treatment lengths, based on achieving
More informationSmart APD prescription. Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong
Smart APD prescription Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong Costing Comparison of Different Modes of RRT in Hong Kong in 2011 (Per Year) HK$300,000 HK$250,000 HK$200,000 HK$150,000
More informationHKMA Community Network HT Management Program
HKMA Community Network HT Management Program Peritoneal Dialysis and Hypertension Dr Siu Yui Pong, Gordon Review of Target BP in non-dialysis CKD patients What are the guidelines? DOQI (Dialysis Outcomes
More informationClinical Grand Rounds BY AL ETINGER AUGUST 2015
Clinical Grand Rounds BY AL ETINGER AUGUST 2015 The Case 51M with a PMHx of ESRD secondary to DM on peritoneal dialysis, type 1 DM, CAD s/p CABG, HFrEF s/p ICD, HTN presents with substernal chest pain.
More informationChronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.
Chronic Kidney Disease (CKD) Stages Stage 1 GFR > 90 (evidence of renal disease) Stage 2 GFR 60-89 Stage 3 GFR 30-59 Stage 4 GFR 15-29 Stage 5 GFR
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES
Date written: November 2004 Final submission: July 2005 Blood urea sampling methods GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions are
More informationDrug Use in Dialysis
(Last Updated: 08/22/2018) Created by: Socco, Samantha Drug Use in Dialysis Drambarean, B. (2017). Drug Use in Dialysis. Lecture presented at PHAR 503 Lecture in UIC College of Pharmacy, Chicago. DIALYSIS
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationPrescription Management: The Tough Cases
Prescription Management: The Tough Cases Western Canada PD Days JOANNE M BARGMAN MD, FRCPC DIRECTOR OF THE PERITONEAL DIALYSIS PROGRAM UNIVERSITY HEALTH NETWORK A review of ancient history my recruitment
More informationSTARTING PERITONEAL DIALYSIS
STARTING PERITONEAL DIALYSIS What you will learn: What your kidneys do What uremia (kidney disease) is and what the symptoms are How Peritoneal Dialysis (PD) helps What the two types of PD are: automated
More informationClinical Guideline Bone chemistry management in adult renal patients on dialysis
Clinical Guideline Bone chemistry management in adult renal patients on dialysis This guidance covers how to: Maintain serum phosphate 0.8 to 1.7mmol/L 1 Maintain serum corrected calcium 2.1 to 2.5mmol/L
More informationPeritoneal Dialysis: An Overview Budapest Nephrology School 2013
Peritoneal Dialysis: An Overview Budapest Nephrology School 2013 Joanne M Bargman MD FRCPC Director, Home Peritoneal Dialysis Unit University Health Network, Toronto The Peritoneal-Vascular Interface dialysate
More informationAdvances in Peritoneal Dialysis, Vol. 29, 2013
Advances in Peritoneal Dialysis, Vol. 29, 2013 Takeyuki Hiramatsu, 1 Takahiro Hayasaki, 1 Akinori Hobo, 1 Shinji Furuta, 1 Koki Kabu, 2 Yukio Tonozuka, 2 Yoshiyasu Iida 1 Icodextrin Eliminates Phosphate
More informationTitle:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients
Author's response to reviews Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients Authors: Da Shang (sdshangda@163.com) Qionghong
More informationFuture Perspectives in Peritoneal Dialysis
Future Perspectives in Peritoneal Dialysis Dialysis Initiatives Nefrologen Meeting September 21, 2017 Joanne M. Bargman MD FRCPC Director, Peritoneal Dialysis Program University Health Network Professor
More informationAdequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial
http://www.kidney-international.org & 2006 International Society of Nephrology original article Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled
More informationThe Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
More informationPD In Acute Kidney Injury. February 7 th -9 th, 2013
PD In Acute Kidney Injury February 7 th -9 th, 2013 Objectives PD as a viable initial therapy PD in AKI PD versus dhd PD versus CVVHD Why not PD first PD for AKI Early days (1970 s) PD was the option of
More informationPrimary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources
August 10, 2007 To: From: RE: Primary Care Physicians and Clinicians XXX on behalf of the Upper Midwest Fistula First Coalition Chronic Kidney Disease (CKD) Resources Caring for patients with chronic kidney
More informationThe greatest benefit of peritoneal dialysis (PD) is the
Peritoneal Dialysis International, Vol. 26, pp. 150 154 Printed in Canada. All rights reserved. 0896-8608/06 $3.00 +.00 Copyright 2006 International Society for Peritoneal Dialysis COMBINATION THERAPY
More informationThe brief of this Canadian Society of Nephrology (CSN)
Peritoneal Dialysis International, Vol. 31, pp. 218-239 doi:10.3747/pdi.2011.00026 0896-8608/11 $3.00 +.00 Copyright 2011 International Society for Peritoneal Dialysis CANADIAN SOCIETY OF NEPHROLOGY GUIDELINES/RECOMMENDATIONS
More informationHyperphosphatemia is a strong predictor of overall
Peritoneal Phosphate Clearance is Influenced by Peritoneal Dialysis Modality, Independent of Peritoneal Transport Characteristics Sunil V. Badve,* Deborah L. Zimmerman,* Greg A. Knoll, * Kevin D. Burns,*
More informationDialysis Adequacy (HD) Guidelines
Dialysis Adequacy (HD) Guidelines Peter Kerr, Convenor (Monash, Victoria) Vlado Perkovic (Camperdown, New South Wales) Jim Petrie (Woolloongabba, Queensland) John Agar (Geelong, Victoria) Alex Disney (Woodville,
More informationGUIDELINE FOR HAEMODIALYSIS PRESCRIPTION FOR NEW PATIENTS COMMENCING HAEMODIALYSIS
GUIDELINE FOR HAEMODIALYSIS PRESCRIPTION FOR NEW PATIENTS COMMENCING HAEMODIALYSIS RRCV CMG Nephrology Service 1. Introduction A first acute or chronic haemodialysis session may induce disequilibrium syndrome
More informationASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM
ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM Medical Management of Home Hemodialysis Patients Brent W. Miller, MD Professor of Medicine Washington University School of Medicine Saint Louis, Missouri
More informationPART FOUR. Metabolism and Nutrition
PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 22, 2006 Costas Fourtounas, Eirini Savidaki, Marilena Roumelioti, Periklis Dousdampanis, Andreas Hardalias, Pantelitsa Kalliakmani,
More informationInnovations in Cardio/Renal Patient Care. Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health at San Antonio Spring Symposium 2018
Innovations in Cardio/Renal Patient Care Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health at San Antonio Spring Symposium 2018 Percent of Patients CVD = cardiovascular disease; ASHD =
More informationManaging Fluid, Diet and Medications
Managing Fluid, Diet and Medications This lesson covers: Fluid and body weight Managing your diet Understanding your medications It is important that you feel comfortable with the information and procedures
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationProceedings of the ISPD 2006 The 11th Congress of the ISPD /07 $ MAXIMIZING THE SUCCESS OF PERITONEAL DIALYSIS IN HIGH TRANSPORTERS
Proceedings of the ISPD 2006 The 11th Congress of the ISPD 0896-8608/07 $3.00 +.00 August 25 29, 2006, Hong Kong Copyright 2007 International Society for Peritoneal Dialysis Peritoneal Dialysis International,
More informationPERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond
PERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond John Burkart, M.D. Wake Forest University Baptist Medical Center CMO Health Systems Management 8/2014 John M. Burkart, MD Educational Grants
More informationCardiorenal and Renocardiac Syndrome
And Renocardiac Syndrome A Vicious Cycle Cardiorenal and Renocardiac Syndrome Type 1 (acute) Acute HF results in acute kidney injury Type 2 Chronic cardiac dysfunction (eg, chronic HF) causes progressive
More informationNo increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four months
Pagniez et al. BMC Nephrology (2017) 18:278 DOI 10.1186/s12882-017-0690-7 RESEARCH ARTICLE No increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four
More informationManagement of early chronic kidney disease
Management of early chronic kidney disease GREENLANE SUMMER GP SYMPOSIUM 2018 Jonathan Hsiao Renal and General Physician Introduction A growing public health problem in NZ and throughout the world. Unknown
More informationThe Urinary System. BIOLOGY OF HUMANS Concepts, Applications, and Issues. Judith Goodenough Betty McGuire
BIOLOGY OF HUMANS Concepts, Applications, and Issues Fifth Edition Judith Goodenough Betty McGuire 16 The Urinary System Lecture Presentation Anne Gasc Hawaii Pacific University and University of Hawaii
More informationPeritoneal Dialysis Adequacy: Not Just Small- Solute Clearance
Advances in Peritoneal Dialysis, Vol. 24, 2008 Rajesh Yalavarthy, Isaac Teitelbaum Peritoneal Dialysis Adequacy: Not Just Small- Solute Clearance Two indices of small-solute clearance, Kt/V urea and creatinine
More informationSequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport
Nephrol Dial Transplant (2013) 28: 447 454 doi: 10.1093/ndt/gfs592 Sequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport Magda Galach 1, Stefan Antosiewicz
More informationSt George Hospital Renal Department: INTERNAL ONLY
HYPOTENSION AND HAEMODIALYSIS THE BOTTOM LINE 1. Prevention of hypotension during haemodialysis (IDH) 2. Treatment of hypotension during haemodialysis (IDH) 3. Withholding dialysis when SBP
More informationUnderstanding Your Medications
PD Education Booklet 8 Understanding Your Medications What you will learn: Why your medications are important Medications your kidney doctor may prescribe, and what they do Medications that may be added
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES
ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level
More informationFrom Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014
From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014 Deux grands principes concernant la DP La dialyse péritonéale doit
More informationImad Ahmed MD. Renal Associates of West Michigan
Imad Ahmed MD Renal Associates of West Michigan ESRD Facts: - Medicare funded program - Cost - Significant mortality and morbidity - Reduced quality of life - Shrinking donor pool ESRD CAUSES - DM - Hypertension
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More informationBasic Fluid and Electrolytes
Basic Fluid and Electrolytes Chapter 22 Basic Fluid and Electrolytes Introduction Infants and young children have a greater need for water and are more vulnerable to alterations in fluid and electrolyte
More informationUnderstanding. Your Kidneys. Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016
Understanding Your Kidneys Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016 Today s Discussion - The Role of your kidneys Common causes of kidney disease Treatment for kidney
More informationEffect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study
Kidney International, Vol. 64 (2003), pp. 649 656 DIALYSIS TRANSPLANTATION Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study WAI-KEI LO, YIU-WING HO, CHUN-SANG
More informationUnderstanding Kt/V and Volume Control
Understanding Kt/V and Volume Control Its practical use to determine dialysis and improve outcomes Caroline Williams RD May 23, 2017 Volume Control in Dialysis Patients Pathogenesis In the 1960s and early
More informationDIURETICS-4 Dr. Shariq Syed
DIURETICS-4 Dr. Shariq Syed AIKTC - Knowledge Resources & Relay Center 1 Pop Quiz!! Loop diuretics act on which transporter PKCC NKCC2 AIKTCC I Don t know AIKTC - Knowledge Resources & Relay Center 2 Pop
More informationIntravenous Iron Requirement in Adult Hemodialysis Patients
Intravenous Iron Requirement in Adult Hemodialysis Patients Timothy V. Nguyen, PharmD The author is a clinical pharmacy specialist with Holy Name Hospital in Teaneck, New Jersey. He is also an adjunct
More informationmean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20).
S44 Figure 53 depicts the trend in Epoetin dosing from the 1998 study period to the 2003 study period, with an increasing mean weekly Epoetin dose (units/kg/wk) for patients prescribed Epoetin in lower
More information